“Findings from a new study led by researchers at Mass General Brigham suggest that rare disease experts are now in favor of more expansive newborn testing. In a study published today in JAMA Network Open, 88 percent of rare disease experts agreed that DNA sequencing to screen for treatable childhood disorders should be made available to all newborns.”
Mass General Brigham-led study finds experts support DNA sequencing in newborns
Mass General Brigham |
May 2023
Press Release